Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value:
$7.24B
Total Bought:
$1.99B
Total Sold:
$1.38B
Net Transaction:
+$606.68M
Notable People:
Behzad Aghazadeh, Avoro Capital L.P.
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Apellis Pharmaceuticals Inc
COM
11,111,11111,111,1110$422.67M$665.11M9.19%+$242.44M
United Therapeutics Corporation(UTHR)2,852,5002,858,888+6,388$644.29M$628.64M8.68%-$15.65M
Ascendis Pharma A/SADR(ASND)3,670,0003,755,555+85,555$343.66M$473.01M6.53%+$129.35M
argenx SEADR(ARGX)1,000,0001,234,567+234,567$491.63M$469.67M6.49%-$21.96M
Madrigal Pharmaceuticals, Inc.(MDGL)1,555,0001,888,888+333,888$227.09M$437.05M6.04%+$209.96M
Sarepta Therapeutics, Inc.(SRPT)4,025,0004,344,444+319,444$487.91M$418.93M5.79%-$68.98M
BioMarin Pharmaceutical Inc.(BMRN)3,850,0004,300,000+450,000$340.65M$414.61M5.73%+$73.96M
Spdr Series Trust - S&p BiotechETF
ST STR SP BIOT
04,444,444+4,444,444$0$396.84M5.48%+$396.84M
Amicus Therapeutics Inc
COM
27,400,00027,400,0000$333.18M$388.81M5.37%+$55.62M
Cerevel Therapeutics Hldng955,5557,555,555+6,600,000$20.86M$320.36M4.42%+$299.50M
Krystal Biotech, Inc.(KRYS)2,565,5552,565,5550$297.60M$318.28M4.40%+$20.68M
Mirati Therapeutics Inc6,666,6664,886,840-1,779,826$290.40M$287.10M3.97%-$3.30M
Cymabay Therapeutics Inc10,300,00011,111,111+811,111$153.57M$262.44M3.63%+$108.87M
Xenon Pharmaceuticals Inc.(XENE)4,900,0005,666,666+766,666$167.38M$261.01M3.61%+$93.62M
Alnylam Pharmaceuticals, Inc.(ALNY)1,011,1111,111,111+100,000$179.07M$212.68M2.94%+$33.61M
Intra-Cellular Therapies Inc02,255,555+2,255,555$0$161.54M2.23%+$161.54M
MoonLake ImmunotherapeuticsCL A(MLTX)1,999,9992,580,000+580,001$114.00M$155.81M2.15%+$41.81M
Kymera Therapeutics, Inc.(KYMR)3,855,0003,775,000-80,000$53.58M$96.11M1.33%+$42.53M
Structure Therapeutics IncADR1,000,0002,333,333+1,333,333$50.42M$95.11M1.31%+$44.69M
Syndax Pharmaceuticals, Inc.(SNDX)2,555,5554,222,222+1,666,667$37.11M$91.24M1.26%+$54.14M
BioCryst Pharmaceuticals, Inc.(BCRX)11,550,00013,050,000+1,500,000$81.77M$78.17M1.08%-$3.60M
Iovance Biotherapeutics, Inc.(IOVA)6,700,0006,700,0000$30.48M$54.47M0.75%+$23.99M
Roivant Sciences Ltd.(ROIV)4,651,1624,651,1620$54.33M$52.23M0.72%-$2.09M
Kura Oncology, Inc.(KURA)2,980,0002,980,0000$27.18M$42.85M0.59%+$15.67M
Spyre Therapeutics, Inc.(SYRE)11,4581,839,138+1,827,680$140.4K$39.58M0.55%+$39.44M
Karuna Therapeutics Inc0125,000+125,000$0$39.56M0.55%+$39.56M
Rocket Pharmaceuticals, Inc.(RCKT)1,250,0001,260,900+10,900$25.61M$37.79M0.52%+$12.18M
Arrowhead Pharmaceuticals, Inc.(ARWR)565,0001,130,000+565,000$15.18M$34.58M0.48%+$19.40M
Marinus Pharmaceuticals Inc3,150,0003,150,0000$25.36M$34.24M0.47%+$8.88M
MannKind Corporation(MNKD)9,000,0009,000,0000$37.17M$32.76M0.45%-$4.41M
Soleno Therapeutics Inc0785,000+785,000$0$31.60M0.44%+$31.60M
Verrica Pharmaceuticals Inc.(VRCA)2,954,0643,999,999+1,045,935$11.48M$29.28M0.40%+$17.80M
Immunogen Inc0875,000+875,000$0$25.94M0.36%+$25.94M
Monte Rosa Therapeutics, Inc.(GLUE)4,535,0004,535,0000$21.72M$25.62M0.35%+$3.90M
Merus N V444,444888,888+444,444$10.48M$24.44M0.34%+$13.96M
Tourmaline Bio Inc0868,407+868,407$0$22.73M0.31%+$22.73M
Avidity Biosciences Inc2,510,0002,510,0000$16.01M$22.72M0.31%+$6.70M
Ultragenyx Pharmaceutical Inc.(RARE)1,500,000350,000-1,150,000$53.48M$16.74M0.23%-$36.74M
Fennec Pharmaceuticals Inc.(FENC)1,200,0001,200,0000$9.01M$13.46M0.19%+$4.45M
Nuvalent Inc812,500178,921-633,579$37.35M$13.17M0.18%-$24.18M
Taysha Gene Therapies, Inc.(TSHA)3,925,0004,355,555+430,555$12.40M$7.71M0.11%-$4.69M
Whitehawk Therapeutics, Inc.(WHWK)2,849,4022,849,4020$13.79M$5.76M0.08%-$8.04M
AKERO THERAPEUTICS ORDCommon555,5550-555,555$28.10M$0—-$28.10M
HORIZON THERAPEUTICS PLCCommon7,000,0000-7,000,000$809.83M$0—-$809.83M
IKENA ONCOLOGY INCCommon1,640,0000-1,640,000$7.10M$0—-$7.10M
IO BIOTECH INCCommon(IOBTQ)2,055,8830-2,055,883$2.84M$0—-$2.84M
PMV PHARMACEUTICALS INCCommon(PMVP)3,000,0000-3,000,000$18.42M$0—-$18.42M
SEAGEN INCCommon1,759,6060-1,759,606$373.30M$0—-$373.30M
SERES THERAPEUTICS INCCommon(MCRB)2,500,0000-2,500,000$5.95M$0—-$5.95M
TALARIS THERAPEUTICS INCCommon500,0000-500,000$1.41M$0—-$1.41M
TANGO THERAPEUTICS INCCommon(TNGX)2,222,2220-2,222,222$25.02M$0—-$25.02M
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q4 2023 | TickerTrail